UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 001-41230
AIB ACQUISITION CORPORATION
(Exact name of registrant as specified in its
charter)
Cayman Islands | | NA |
(State
or other jurisdiction of
incorporation or organization) | | (I.R.S.
Employer
Identification No.) |
875 Third Avenue, Suite M204A
New York, New York, 10022
(Address of Principal Executive Offices, including
zip code)
(212) 380-8128
(Registrant’s telephone number, including
area code)
N/A
(Former name, former address and former fiscal year,
if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one Class A Ordinary Share and one Right to receive one-tenth (1/10) of one Class A Ordinary Share upon the consummation of an initial business combination | | AIBBU | | The Nasdaq Stock Market LLC |
Class A Ordinary Shares, par value $0.0001 per share | | AIB | | The Nasdaq Stock Market LLC |
Rights, every ten (10) rights entitles the holder to receive one Class A Ordinary Share upon the consummation of an initial combination | | AIBBR | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1)
has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has
submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes ☒ No ☐
Indicate by
check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a
shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☒ No ☐
As of August 11, 2023, there were 1,472,277
Class A ordinary shares, par value $0.0001 per share and 2,156,250 of the Company’s Class B ordinary shares, par value
$0.0001 per share, of the registrant issued and outstanding.
AIB ACQUISITION CORPORATION
Quarterly Report on Form 10-Q
TABLE OF CONTENTS
Item 1. Interim Financial Statements
AIB ACQUISITION CORPORATION
CONDENSED BALANCE SHEETS
| |
June 30, 2023 | | |
December 31, 2022 | |
| |
(Unaudited) | | |
| |
ASSETS |
CURRENT ASSETS | |
| | |
| |
Cash | |
$ | 131,567 | | |
$ | 44,217 | |
Prepaid expenses - current | |
| 78,315 | | |
| 67,963 | |
Investments held in Trust Account - current | |
| 10,911,923 | | |
| — | |
Total current assets | |
| 11,121,805 | | |
| 112,180 | |
| |
| | | |
| | |
Investments held in Trust Account - non-current | |
| — | | |
| 88,525,575 | |
TOTAL ASSETS | |
$ | 11,121,805 | | |
$ | 88,637,755 | |
LIABILITIES, REDEEMABLE CLASS A ORDINARY SHARES, AND SHAREHOLDERS’ DEFICIT | |
| | | |
| | |
CURRENT LIABILITIES | |
| | | |
| | |
Accounts payable and accrued expenses | |
$ | 325,897 | | |
$ | 130,491 | |
Promissory note - related party | |
| 300,000 | | |
| — | |
Advance from related party | |
| 193,965 | | |
| 41,465 | |
Convertible note - related party | |
| 500,000 | | |
| — | |
Deferred underwriting fee - current | |
| 3,018,750 | | |
| — | |
Total current liabilities | |
| 4,338,612 | | |
| 171,956 | |
LONG TERM LIABILITIES | |
| | | |
| | |
Deferred underwriting fee - non-current | |
| — | | |
| 3,018,750 | |
TOTAL LIABILITIES | |
| 4,338,612 | | |
| 3,190,706 | |
| |
| | | |
| | |
COMMITMENTS AND CONTINGENCIES (NOTE 6) | |
| | | |
| | |
REDEEMABLE CLASS A ORDINARY SHARES | |
| | | |
| | |
Class A ordinary shares subject to possible redemption, $0.0001 par value, 1,001,302 and 8,625,000 shares at redemption value of $10.89 and $10.26 per share at June 30, 2023 and December 31, 2022, respectively | |
| 10,911,923 | | |
| 88,525,575 | |
SHAREHOLDERS’ DEFICIT | |
| | | |
| | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | |
| — | | |
| — | |
Class A ordinary shares; $0.0001 par value; 50,000,000 shares authorized; 470,975 shares issued and outstanding at June 30, 2023 and December 31, 2022 | |
| 47 | | |
| 47 | |
Class B ordinary shares; $0.0001 par value; 3,000,000 shares authorized; 2,156,250 shares issued and outstanding at June 30, 2023 and December 31, 2022 | |
| 215 | | |
| 215 | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (4,128,992 | ) | |
| (3,078,788 | ) |
TOTAL SHAREHOLDERS’ DEFICIT | |
$ | (4,128,730 | ) | |
$ | (3,078,526 | ) |
TOTAL LIABILITIES, REDEEMABLE CLASS A ORDINARY SHARES, AND SHAREHOLDERS’ DEFICIT | |
$ | 11,121,805 | | |
$ | 88,637,755 | |
The accompanying notes are an integral part
of these unaudited condensed financial statements
AIB ACQUISITION CORPORATION
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
| |
For the Three Months Ended
June 30, | | |
For the Six Months Ended
June 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
| | |
| | |
| | |
| |
General and administrative expenses | |
$ | 461,528 | | |
$ | 193,269 | | |
$ | 750,204 | | |
$ | 421,399 | |
Loss from operations | |
| (461,528 | ) | |
| (193,269 | ) | |
| (750,204 | ) | |
| (421,399 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other income: | |
| | | |
| | | |
| | | |
| | |
Interest earned on investments held in Trust Account | |
| 130,370 | | |
| 129,328 | | |
| 407,099 | | |
| 161,417 | |
Unrealized gain (loss) on investments held in Trust Account | |
| 651 | | |
| (7,526 | ) | |
| 3,725 | | |
| (13,518 | ) |
Total other income, net | |
| 131,021 | | |
| 121,802 | | |
| 410,824 | | |
| 147,899 | |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (330,507 | ) | |
$ | (71,467 | ) | |
$ | (339,380 | ) | |
$ | (273,500 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average shares of redeemable Class A ordinary shares outstanding, basic and diluted | |
| 1,001,302 | | |
| 8,625,000 | | |
| 1,717,340 | | |
| 7,624,309 | |
Basic and diluted net income (loss) per share, Class A redeemable | |
$ | 0.11 | | |
$ | (0.00 | ) | |
$ | 0.17 | | |
$ | 0.40 | |
| |
| | | |
| | | |
| | | |
| | |
Weighted average shares of non-redeemable Class A ordinary shares outstanding, basic and diluted | |
| 470,975 | | |
| 470,975 | | |
| 470,975 | | |
| 416,331 | |
Basic and diluted net loss per share, Class A non-redeemable | |
$ | (0.17 | ) | |
$ | (0.02 | ) | |
$ | (0.24 | ) | |
$ | (1.28 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average shares of Class B ordinary shares outstanding, basic and diluted | |
| 2,156,250 | | |
| 2,156,250 | | |
| 2,156,250 | | |
| 2,156,250 | |
Basic and diluted net loss per share, Class B | |
$ | (0.17 | ) | |
$ | (0.02 | ) | |
$ | (0.24 | ) | |
$ | (1.28 | ) |
The accompanying notes are an integral part
of these unaudited condensed financial statements
AIB ACQUISITION CORPORATION
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’
DEFICIT
(UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED JUNE 30,
2023
| |
Ordinary Shares | | |
Additional | | |
| | |
Total | |
| |
Class A | | |
Class B | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance — December 31, 2022 | |
| 470,975 | | |
$ | 47 | | |
| 2,156,250 | | |
$ | 215 | | |
$ | — | | |
$ | (3,078,788 | ) | |
$ | (3,078,526 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accretion for Class A Ordinary Shares to redemption value | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (429,803 | ) | |
| (429,803 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (8,873 | ) | |
| (8,873 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance — March 31, 2023 | |
| 470,975 | | |
| 47 | | |
| 2,156,250 | | |
| 215 | | |
| — | | |
| (3,517,464 | ) | |
| (3,517,202 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accretion for Class A Ordinary Shares to redemption value | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (281,021 | ) | |
| (281,021 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (330,507 | ) | |
| (330,507 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance — June 30, 2023 | |
| 470,975 | | |
$ | 47 | | |
| 2,156,250 | | |
$ | 215 | | |
$ | — | | |
$ | (4,128,992 | ) | |
$ | (4,128,730 | ) |
FOR THE THREE AND SIX MONTHS ENDED JUNE 30,
2022
| |
Ordinary Shares | | |
Additional | | |
| | |
Total Shareholders’ | |
| |
Class A | | |
Class B | | |
Paid-in | | |
Accumulated | | |
Equity | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
(Deficit) | |
Balance — December 31, 2021 | |
| — | | |
$ | — | | |
| 2,156,250 | | |
$ | 215 | | |
$ | 24,785 | | |
$ | (23,277 | ) | |
$ | 1,723 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Proceeds from Initial Public Offering (net of offering costs) | |
| — | | |
| — | | |
| — | | |
| — | | |
| 5,844,179 | | |
| — | | |
| 5,844,179 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Sale of Private Units | |
| 388,750 | | |
| 39 | | |
| — | | |
| — | | |
| 3,887,461 | | |
| — | | |
| 3,887,500 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Representative Shares Issuance | |
| 82,225 | | |
| 8 | | |
| — | | |
| — | | |
| 597,992 | | |
| — | | |
| 598,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Excess Value of Unit Purchase Option | |
| — | | |
| — | | |
| — | | |
| — | | |
| 56,000 | | |
| — | | |
| 56,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accretion for Class A Ordinary Shares to redemption value | |
| — | | |
| — | | |
| — | | |
| — | | |
| (10,410,417 | ) | |
| (2,230,847 | ) | |
| (12,641,264 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (202,033 | ) | |
| (202,033 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance — March 31, 2022 | |
| 470,975 | | |
| 47 | | |
| 2,156,250 | | |
| 215 | | |
| — | | |
| (2,456,157 | ) | |
| (2,455,895 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (71,467 | ) | |
| (71,467 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance — June 30, 2022 | |
| 470,975 | | |
$ | 47 | | |
| 2,156,250 | | |
$ | 215 | | |
| — | | |
$ | (2,527,624 | ) | |
$ | (2,527,362 | ) |
The accompanying notes
are an integral part of these unaudited condensed financial statements
AIB ACQUISITION CORPORATION
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| |
For the Six Months Ended June 30, | |
| |
2023 | | |
2022 | |
Cash Flows from Operating Activities: | |
| | |
| |
Net loss | |
$ | (339,380 | ) | |
$ | (273,500 | ) |
Adjustments to reconcile loss to net cash used in operating activities: | |
| | | |
| | |
Interest earned on investments held in Trust Account | |
| (407,099 | ) | |
| (161,417 | ) |
Unrealized (gain) loss on investments held in Trust Account | |
| (3,725 | ) | |
| 13,518 | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses and other assets | |
| (10,352 | ) | |
| (88,567 | ) |
Non-current prepaid expenses | |
| — | | |
| (20,065 | ) |
Accounts payable and accrued expenses | |
| 195,406 | | |
| 54,349 | |
Net cash used in operating activities | |
| (565,150 | ) | |
| (475,682 | ) |
| |
| | | |
| | |
Cash Flows from Investing Activities: | |
| | | |
| | |
Investment of cash into Trust Account | |
| (300,000 | ) | |
| (87,112,500 | ) |
Cash withdrawn from Trust Account in connection with redemption | |
| 78,324,476 | | |
| — | |
Net cash provided by (used in) investing activities | |
| 78,024,476 | | |
| (87,112,500 | ) |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Payment of offering costs | |
| — | | |
| (291,340 | ) |
Proceeds from initial public offering, net of underwriters’ discount | |
| — | | |
| 84,525,000 | |
Proceeds from private placement | |
| — | | |
| 3,861,055 | |
Advances from related party | |
| 254,598 | | |
| — | |
Repayment of advances from related party | |
| (102,098 | ) | |
| — | |
Proceeds from promissory note – related party | |
| 300,000 | | |
| — | |
Proceeds from convertible promissory note – related party | |
| 500,000 | | |
| — | |
Redemption of ordinary shares | |
| (78,324,476 | ) | |
| — | |
Repayment of Sponsor loan | |
| — | | |
| (272,500 | ) |
Net cash (used in) provided by financing activities | |
| (77,371,976 | ) | |
| 87,822,215 | |
| |
| | | |
| | |
Net Change in Cash | |
| 87,350 | | |
| 234,033 | |
Cash – Beginning of period | |
| 44,217 | | |
| 45,370 | |
Cash – End of period | |
$ | 131,567 | | |
$ | 279,403 | |
| |
| | | |
| | |
Non-cash investing and financing activities: | |
| | | |
| | |
Deferred underwriting commissions payable charged to additional paid in capital | |
$ | — | | |
$ | 3,018,750 | |
Increase in due from related party | |
$ | — | | |
$ | 26,445 | |
The accompanying notes are an integral part
of these unaudited condensed financial statements
AIB ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2023
(UNAUDITED)
Note 1 — Description of Organization and Business Operations
and Liquidity
AIB Acquisition Corporation
(the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on June 18, 2021. The Company
was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization
or similar business combination with one or more businesses (“Business Combination”).
The Company is not limited
to a particular industry or geographic region for purposes of completing a Business Combination, although the Company intends to focus
on business in the fintech industry. Notwithstanding the foregoing, we will not pursue a target business that is headquartered in, or
conducts a majority of its business in, China or Hong Kong. The Company is an early stage and emerging growth company and, as such, the
Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30, 2023, the Company had not commenced any operations.
All activity from June 18, 2021 (inception) through June 30, 2023, relates to the Company’s formation and initial public offering
(“IPO”), which is described below and, since the IPO, the search for a prospective Business Combination. The Company will
not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will
generate non-operating income in the form of interest income earned on investments from the proceeds derived from the IPO. The registration
statement for the Company’s IPO was declared effective on January 18, 2022. On January 21, 2022, the Company consummated the IPO
of 7,500,000 units (“Units”) with respect to the Class A ordinary shares (“Class A ordinary shares”) included
in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $75,000,000, which is
discussed in Note 3. The Company has selected December 31 as its fiscal year end.
Simultaneously with the
closing of the IPO, the Company consummated the sale of 355,000 private placement units (“Private Placement Units”) at a
price of $10.00 per Private Placement Unit in a private placement to the Company’s sponsor, AIB LLC (the “Sponsor”),
and Maxim Group, LLC (“Maxim”) generating gross proceeds of $3,550,000 which is described in Note 4.
Simultaneously with the
closing of the IPO and the sale of the Private Placement Units, the Company consummated the closing of the sale of 1,125,000 additional
Units upon receiving notice of the underwriter’s election to fully exercise its overallotment option (“Overallotment Units”),
generating additional gross proceeds of $11,250,000. Simultaneously with the exercise of the Overallotment Units, the Company consummated
the private placement of an additional 33,750 Private Placement Units to the Sponsor and Maxim, generating gross proceeds of $337,500.
Offering costs for the IPO
and Overallotment Units amounted to $5,941,695, consisting of $1,725,000 of underwriting fees, $3,018,750 of deferred underwriting fees
payable (which are held in a trust account (the “Trust Account”)), $56,000 for the underwriter’s unit purchase option
(see Note 6), $598,000 for the issuance of representative shares to the underwriters (see Note 7) and $543,945 of other costs. As described
in Note 6, the $3,018,750 of deferred underwriting fees payable is contingent upon the consummation of a Business Combination, subject
to the terms of the underwriting agreement.
Following the closing of
the IPO and Overallotment Units, $87,112,500 ($10.10 per Unit) from the net proceeds of the sale of the Units in the IPO, Overallotment
Units, and the Private Placement Units were placed in the trust account. The amounts placed in the Trust Account will be invested in U.S.
government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment
Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market
fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment
Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution
of the Trust Account, as described below.
The Company’s management
has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There
is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more
initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding
the amounts due under the business combination marketing agreement and taxes payable on income earned on the Trust Account) at the time
of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the
post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling
interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There
is no assurance the Company will be able to successfully effect a Business Combination.
The Company will provide
the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion
of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called
to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.10 per Public
Share, plus any pro rata interest then in the Trust Account, net of taxes payable).
All of the Public Shares
contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation,
if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain
amendments to the Company’s amended and restated certificate of incorporation. In accordance with Financial Accounting Standards
Board (“FASB”) Accounting Standards Codification (“ASC”) Topis 480 “Distinguishing Liabilities from Equity”
(“ASC 480”) Subtopic 10-S99, redemption provisions not solely within the control of a company require Class A ordinary shares
subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding
instruments (i.e., Public Rights as defined in Note 3), the initial carrying value of the Public Shares classified as temporary equity
will be the allocated proceeds determined in accordance with ASC 470-20 “Debt with Conversion and other Options”. The Public
Shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option
to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable
that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the
redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of
each reporting period. The Company has elected to recognize the changes immediately. While redemptions cannot cause the Company’s
net tangible assets to fall below $5,000,001, the Public Shares are redeemable and are classified as such on the balance sheet until such
date that a redemption event takes place.
Redemptions of the Company’s
Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to
the Company’s Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed
with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required
by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the
Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated
Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange
Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder
approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder
approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the
proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination,
the Sponsor has agreed to vote its Founder Shares (as defined in Note 2) and any Public Shares purchased during or after the IPO in favor
of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and
if they do vote, irrespective of whether they vote for or against the proposed transaction.
Notwithstanding the foregoing,
the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such
shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with
respect to more than an aggregate of 15% or more of the Public Shares sold in the IPO, without the prior consent of the Company.
The Company’s Sponsor,
officers and directors (the “Initial Shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum
and Articles of Association that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public
Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity
to redeem their shares of Class A ordinary shares in conjunction with any such amendment.
On January 18, 2023 the
Company held an extraordinary general meeting of shareholders (the “Meeting”) and approved, among other things, amendments
to the second amended and restated memorandum and articles of association (the “Extension Amendment”) to (i) extend the date
by which we must consummate an initial Business Combination from January 21, 2023 to October 21, 2023, and (ii) to permit the board of
directors of the Company (the “Board”), in its sole discretion, to elect to wind up our operations on an earlier date than
October 21, 2023. In connection with the Extension Amendments, shareholders holding 7,623,698 ordinary shares exercised their right to
redeem such shares for a pro rata portion of the Trust Account. As a result of the Extension Redemption, an aggregate amount of $78,324,475.94
(approximately $10.27 per share) was removed from the Trust Account to pay such holders.
If the Company is unable
to complete a Business Combination by October 21, 2023, the extended date (the “Combination Period”), the Company will (i) cease
all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust
Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay (i) its income
and franchise taxes and (ii) up to $100,000 of dissolution expenses, if any, divided by the number of then outstanding Public Shares,
which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further
liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Company’s remaining shareholders and the Company’s Board, dissolve and liquidate, subject in
each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other
applicable law.
On January 19, 2023, upon
the shareholders’ approval of the trust amendment proposal, the Company entered into an amendment (the “Trust Amendment”)
to the Investment Management Trust Agreement, dated January 18, 2022 (the “Trust Agreement”), by and between the Company and
Continental Stock Transfer & Trust Company, as trustee (“Continental”), to extend the date by which the Company would
be required to consummate a Business Combination from January 21, 2023 to October 21, 2023, or such earlier date as determined by the
Board, in its sole discretion.
On January 20, 2023, the
Company issued a promissory note (the “Extension Note”) in the aggregate principal amount of up to $450,000 to the Sponsor
(the “Extension Funds”), pursuant to which the Extension Funds will be deposited into the Trust Account in monthly installments
for the benefit of each Public Share that was not redeemed in connection with the extension of the Company’s termination date from
January 21, 2023 to October 21, 2023. The Sponsor has agreed to pay $50,000 per month (or $0.05 per Public Share not redeemed) that the
Company decides to take to complete an initial Business Combination, commencing on January 21, 2023 and continuing through October 21,
2023, or portion thereof, that is needed to complete an initial Business Combination, for up to an aggregate of $450,000. On January 20,
2023, the first installment of the Extension Funds was deposited into the Trust Account. The Extension Note bears no interest and is repayable
in full upon the earlier of (a) the date of the consummation of the initial Business Combination, and (b) the date of the liquidation
of the Company.
The Initial Shareholders
have agreed to waive their liquidation rights with respect to the Founder Shares (as defined in Note 2) if the Company fails to complete
a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the
IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to its deferred
underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within
the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be
available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of
the residual assets remaining available for distribution (including Trust Account assets) will be only $10.10 per share initially held
in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if
and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with
which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability
will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in
or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the IPO against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the
extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or
other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.
On May 11, 2023, we received
a deficiency letter from the Listing Qualifications Department (the “Staff”) of Nasdaq notifying the Company that, for the
preceding 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the $50 million
minimum requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS
Requirement”).
Also on May 11, 2023, we
received a deficiency letter from the Staff of Nasdaq notifying the Company that, for the preceding 30 consecutive business days, the
Company’s Market Value of Publicly Held Shares (“MVPHS”) was below the $15 million minimum requirement for continued
inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(3)(C) (the “MVPHS Requirement”).
The notifications received
have no immediate effect on the Company’s Nasdaq listing. The Nasdaq Listing Rules provide the Company a compliance period of 180
calendar days in which to regain compliance. If at any time during this compliance period, the Company’s MVLS closes at $50 million
or more and the Company’s MVPHS closes at $15 million or more for a minimum of ten consecutive business days, Nasdaq will provide
the Company written confirmation of compliance.
The Company intends to
monitor the market value of the Company’s listed securities and may, if appropriate, consider available options to regain compliance
with the MVLS and MVPHS Requirements.
Risks and Uncertainties
Management continues to
evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a
negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific
impact is not readily determinable as of the date of these unaudited condensed financial statements. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian
Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including
the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action
and related sanctions on the world economy is not determinable as of the date of these unaudited condensed financial statements. The
specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the
date of these unaudited condensed financial statements.
On August 16, 2022, the
Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things,
a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations
and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation
itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value
of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations
are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the
same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”)
has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
The IR Act applies only to repurchases that occur after December 31, 2022.
Any redemption or other
repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject
to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination,
extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases
in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and
amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection
with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and
other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder,
the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available
on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. Because there is a
possibility that the Company may acquire a U.S. domestic corporation or engage in a transaction in which a domestic corporation becomes
our parent or our affiliate and our securities will trade on Nasdaq following the date of this prospectus, we may become a “covered
corporation”.
Liquidity and Going Concern
As of June 30, 2023, the Company
had $131,567 in its operating bank account, and working capital deficit of $609,980, which excludes investments held in the Trust Account,
the liability for convertible note and deferred underwriting fee.
The Company’s liquidity
needs up to the closing of the IPO on January 21, 2022 had been satisfied through proceeds from notes payable and advances from related
party and from the issuance of ordinary shares.
In order to finance transaction
costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s
officers and directors may, but are not obligated to, provide the Company with working capital. The Company’s management plans to
continue its efforts to complete a Business Combination within the Combination Period after the closing of the IPO.
If our estimate of the costs
of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount
necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may
need to obtain other financing either to complete our Business Combination or because we become obligated to redeem a significant number
of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in
connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing
simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not
have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our
Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
On January 19, 2023, upon the
shareholders’ approval of the Trust Amendment Proposal, the Company entered into the Trust Amendment to extend the date by which
the Company would be required to consummate a Business Combination from January 21, 2023 to October 21, 2023, or such earlier date as
determined by the Board, in its sole discretion. As a result, we have up to 21 months from the closing of the IPO on January 21, 2022
to consummate a Business Combination, unless further extended as permitted by our charter. It is uncertain that we will be able to consummate
a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation
and subsequent dissolution.
In connection with the Company’s
assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements —
Going Concern”, management has determined that mandatory liquidation, should a Business Combination not occur, and potential subsequent
dissolution raises substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time,
which is considered to be one year from the issuance of the financial statements.
Note 2 — Summary of Significant Accounting Policies
Basis of Presentation
The accompanying financial statements
of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”)
and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.
The accompanying unaudited
condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, as filed with the SEC
on March 29, 2023. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results
to be expected for the year ending December 31, 2023 or for any future interim periods.
Emerging Growth Company
The Company is an “emerging
growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure
obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.
The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such
extended transition period which means that when a standard is issued or revised and it has different application dates for public or
private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt
the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is
neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses
during the reporting period.
Making estimates requires
management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly
from those estimates.
Cash and Cash Equivalents
The Company considers all
short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $131,567
and $44,217 in cash and did not have any cash equivalents as of June 30, 2023 and December 31, 2022, respectively.
Investments Held in Trust Account
At June 30, 2023 and December
31, 2022, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company’s investments
held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value
at the end of each reporting period. Earnings on these trading securities are included in dividends, interest earned, and unrealized
gain on investments held in Trust Account in the accompanying statements of operations and are automatically reinvested therefore are
considered as an adjustment to reconcile net income (loss) to net cash used in operating activities in the condensed statements of cash
flows. The fair value for these trading securities are determined using quoted market prices in active markets for identical assets.
During the six months ended June
30, 2023, interest earned from the Trust Account amounted to $407,099 (including $94,596 accrued interest on investments purchased on
April 27, 2023 maturing on July 27, 2023) of which $407,099 was reinvested and $0 was held in Cash in the Trust Account. $3,725 was also
recognized as unrealized gain on investments held in the Trust Account during the six months ended June 30, 2023. There was $78,324,476
of withdrawal made during the six months ended June 30, 2023 in connection with the with the shareholders’ vote at the Meeting,
in which shareholders holding 7,623,698 shares of the Company’s ordinary shares exercised their right to redeem such shares for
a pro rata portion of the funds in the Company’s Trust Account.
Class A Ordinary shares subject to Possible Redemption
The Company accounts for
its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A ordinary shares
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the
holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified
as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Public
Shares sold in the IPO feature certain redemption rights that are considered to be outside of the Company’s control and subject
to occurrence of uncertain future events.
In connection with the
Meeting held on January 18, 2023, shareholders holding 7,623,698 shares of the Company’s ordinary shares exercised their right
to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account.
Accordingly, on June 30,
2023 and December 31, 2022, 1,001,302 and 8,625,000 shares of Class A ordinary shares subject to possible redemption are presented as
temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets, respectively.
As of June 30, 2023 and
December 31, 2022, the shares of Class A ordinary shares subject to possible redemption reflected on the balance sheet are reconciled
on the following table:
Gross proceeds | |
$ | 86,250,000 | |
Less: | |
| | |
Fair value of Public Rights at issuance | |
| (6,272,000 | ) |
Class A shares issuance costs | |
| (5,506,764 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 14,054,339 | |
Class A ordinary shares subject to possible redemption, December 31, 2022 | |
| 88,525,575 | |
Less: | |
| | |
Redemption – January 18, 2023 | |
| (78,324,476 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 710,824 | |
Class A ordinary shares subject to possible redemption, June 30, 2023 | |
$ | 10,911,923 | |
Offering Costs associated with the Initial Public Offering
Offering costs consist
principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs amounted to $5,941,695
which were charged against shareholders’ deficit upon the completion of the IPO.
Concentration of Credit Risk
Financial instruments that
potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times,
may exceed the Federal Depository Insurance Corporation limit of $250,000. As of June 30, 2023 and December 31, 2022, the Company has
not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments
The fair value of the Company’s
assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,”
equals or approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.
Income Taxes
The Company complies with
the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach
to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between
the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted
tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
FASB ASC 740, “Income
Taxes”, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2023 and December
31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company
is not currently aware of any issues under review that could result in significant payments, accruals, or material deviation from its
position. The Company is subject to tax examinations by major taxing authorities since inception. There is currently no taxation imposed
by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company.
Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect
that the total amount of unrecognized tax benefits will materially change over the next twelve months.
There is currently no taxation
imposed by the Government of the Cayman Islands. The Company has no connection to any other taxable jurisdiction and is presently not
subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. Consequently, income taxes are
not reflected in the Company’s financial statements.
Net Income (Loss) Per Ordinary Share
The Company has two outstanding
classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares (the “Founder Shares”). Class
A shares include redeemable and non-redeemable shares. Earnings and losses are shared pro rata between the two classes of shares which
includes Class A ordinary shares and Class B ordinary shares and between the redeemable and the non-redeemable shares. The 1,472,277
Class A ordinary shares for which the outstanding Public Rights and Private Placement Rights are exercisable were excluded from diluted
earnings per share for the period ended June 30, 2023 and 2022 because they are contingently exercisable, and the contingencies have
not yet been met. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the period. The
table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each
class of shares.
FOR THE THREE MONTHS ENDED JUNE 30, 2023 |
| |
Redeemable | | |
Non-redeemable | |
NUMERATOR | |
Class A | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| |
Allocation of net loss | |
$ | (168,753 | ) | |
$ | (79,375 | ) | |
$ | (363,400 | ) |
Net loss including accretion of temporary equity to redemption value | |
| 281,021 | | |
| — | | |
| — | |
Net income (loss) | |
$ | 112,268 | | |
$ | (79,375 | ) | |
$ | (363,400 | ) |
Denominator: | |
| | | |
| | | |
| | |
Weighted Average Shares Outstanding including ordinary shares subject to redemption | |
| 1,001,302 | | |
| 470,975 | | |
| 2,156,250 | |
Basic and diluted net income (loss) per share | |
$ | 0.11 | | |
$ | (0.17 | ) | |
$ | (0.17 | ) |
FOR THE SIX MONTHS ENDED JUNE 30, 2023 |
| |
Redeemable | | |
Non-redeemable | |
NUMERATOR | |
Class A | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| |
Allocation of net loss | |
$ | (415,130 | ) | |
$ | (113,847 | ) | |
$ | (521,227 | ) |
Net loss including accretion of temporary equity to redemption value | |
| 710,824 | | |
| — | | |
| — | |
Net income (loss) | |
$ | 295,694 | | |
$ | (113,847 | ) | |
$ | (521,227 | ) |
Denominator: | |
| | | |
| | | |
| | |
Weighted Average Shares Outstanding including ordinary shares subject to redemption | |
| 1,717,340 | | |
| 470,975 | | |
| 2,156,250 | |
Basic and diluted net income (loss) per share | |
$ | 0.17 | | |
$ | (0.24 | ) | |
$ | (0.24 | ) |
FOR THE THREE MONTHS ENDED JUNE 30, 2022 |
| |
Redeemable | | |
Non-redeemable | |
NUMERATOR | |
Class A | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| |
Allocation of net loss | |
$ | (148,144 | ) | |
$ | (8,089 | ) | |
$ | (37,036 | ) |
Net loss including accretion of temporary equity to redemption value | |
| 121,802 | | |
| — | | |
| — | |
Net loss | |
$ | (26,342 | ) | |
$ | (8,089 | ) | |
$ | (37,036 | ) |
Denominator: | |
| | | |
| | | |
| | |
Weighted Average Shares Outstanding including ordinary shares subject to redemption | |
| 8,625,000 | | |
| 470,975 | | |
| 2,156,250 | |
Basic and diluted net loss per share | |
$ | (0.00 | ) | |
$ | (0.02 | ) | |
$ | (0.02 | ) |
FOR THE SIX MONTHS ENDED JUNE 30, 2022 |
| |
Redeemable | | |
Non-redeemable | |
NUMERATOR | |
Class A | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| |
Allocation of net loss | |
$ | (9,767,074 | ) | |
$ | (533,339 | ) | |
$ | (2,762,250 | ) |
Accretion of temporary equity to redemption value | |
| 12,641,264 | | |
| — | | |
| — | |
Net income including accretion of temporary equity to redemption value | |
| 147,899 | | |
| — | | |
| — | |
Net income (loss) | |
$ | 3,022,089 | | |
$ | (533,339 | ) | |
$ | (2,762,250 | ) |
Denominator: | |
| | | |
| | | |
| | |
Weighted Average Shares Outstanding including ordinary shares subject to redemption | |
| 7,624,309 | | |
| 416,331 | | |
| 2,156,250 | |
Basic and diluted net income (loss) per share | |
$ | 0.40 | | |
$ | (1.28 | ) | |
$ | (1.28 | ) |
Note 3 — Initial Public Offering and
Over-Allotment
Pursuant to the IPO, the
Company sold 8,625,000 Units (including 1,125,000 Overallotment Units) at a price of $10.00 per Unit. Each Unit consists of one share
of Class A ordinary shares and one right (the “Public Rights”). Each Public Right entitles the holder to receive one-tenth
(1/10) of one Class A ordinary share upon the consummation of a Business Combination (see Note 7).
In connection with the
Meeting held on January 18, 2023, shareholders holding 7,623,698 shares of the Company’s ordinary shares exercised their right
to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account.
Note 4 — Private Placement
On January 21, 2022,
simultaneously with the consummation of the IPO and sale of the Overallotment Units, the Company consummated the issuance and sale of
388,750 Private Placement Units (including 33,750 Private Placement Units purchased simultaneously with the Overallotment Units) in a
private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $3,887,500 to the Sponsor
(345,625 Private Placement Units) and Maxim (43,125 Private Placement Units). Each Private Placement Unit consists of one share
of Class A ordinary shares and one right (the “Private Placement Rights”). Each Private Placement Right will entitle the
holder thereof to receive one-tenth (1/10) of one Class A ordinary (“Private Placement Share”) share upon the consummation
of a Business Combination.
A portion of the proceeds
from the Private Placement Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete
a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund
the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units and any underlying
securities will be worthless.
Note 5 — Related Party Transactions
Founder Shares
On July 30, 2021, the Sponsor
purchased 1,437,500 Founder Shares for an aggregate price of $25,000 (See Note 7). On September 13, 2021, the Company effected a 0.5-for-1
split of the Company’s Class B ordinary shares, such that the Sponsor owned 2,156,250 Founder Shares. The Founder Shares will automatically
convert into shares of Class A ordinary shares at the time of the Company’s initial Business Combination and are subject to certain
transfer restrictions, as described in Note 7. Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares
into an equal number of shares of Class A ordinary shares, subject to adjustment, at any time. The Initial Shareholders agreed to forfeit
up to 281,250 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. Since the overallotment
option was exercised in full, the 281,250 Founder Shares are no longer subject to forfeiture.
The Sponsor has agreed,
subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) six months
after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A
ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or
(y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction
that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities
or other property.
Administrative Services Agreement
The Company intends to
pay the Sponsor a fee of up to $10,000 per month for the use of office and administrative support services following the consummation
of the IPO until the earlier of the consummation of the Business combination or liquidation for office space and administrative services.
For the three and six months ended June 30, 2023, the Company incurred $30,000 and $60,000 fees for these services, respectively, of
which $10,000 of such fees is included in advance from related party in the accompanying balance sheet as of June 30, 2023 For the three
and six months ended June 30, 2022, the Company incurred and paid $30,000 and $54,000 fees for these services, respectively.
Promissory Note – Related Party
On July 30, 2021, the Sponsor
agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”).
The Note is non-interest bearing. On January 21, 2022, the Note was repaid in full.
Related Party Loans
In addition, in order to
finance transaction costs in connection with a Business Combination, certain of the Company’s officers and directors may, but are
not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business
Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise,
the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital
Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either
be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of
such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. These
units would be identical to the Private Placement Units.
On January 23, 2023, the Company
issued a Note in the principal amount of up to $500,000 to the Sponsor. The Note was issued in connection with advances the Sponsor has
made, and may make in the future, to the Company for working capital expenses. The Note bears no interest and is due and payable upon
the earlier to occur of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding
up of the Company is effective. At the election of the Sponsor, up to $500,000 of the unpaid principal amount of the Note may be converted
into Units of the Company, each unit consisting of one Class A ordinary share of the Maker and one right exchangeable into one-tenth of
one Class A ordinary share of the Company (the “Conversion Units”), equal to: (x) the portion of the principal amount of this
Note being converted, divided by (y) $10.00, rounded up to the nearest whole number of Units. The Conversion Units are identical to the
units issued by the Company to the Sponsor in the private placement upon consummation of the Company’s IPO. The Conversion Units
and their underlying securities are entitled to the registration rights set forth in the Note.
As of June 30, 2023 and
December 31, 2022, there was $500,000 and $0, related party loans outstanding, respectively.
Related Party Extension Loans
As discussed in Note 1,
the Company may extend the period of time to consummate a Business Combination up to three times, each by an additional three months
(for a total of 21 months to complete a Business Combination). In order to extend the time available for the Company to consummate a
Business Combination, the Sponsor or its affiliates or designees must deposit into the Trust Account $862,500 ($0.10 per Public Share
or an aggregate of $2,587,500), on or prior to the date of the applicable deadline, for each three month extension. Any such payments
would be made in the form of a non-interest bearing, unsecured promissory note. Such notes would be paid upon consummation of a Business
Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company
to complete a Business Combination.
On January 20, 2023, the Company
issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor, the Company’s Sponsor, pursuant to
which the Extension Funds will be deposited into the Trust Account in monthly installments for the benefit of each outstanding Public
Share that was not redeemed in connection with the extension of the Company’s termination date from January 21, 2023 to October
21, 2023. The Sponsor has agreed to pay $50,000 per month (or $0.05 per Public Share not redeemed) that the Company decides to take to
complete an initial Business Combination, commencing on January 21, 2023 and continuing through October 21, 2023, or portion thereof,
that is needed to complete an initial Business Combination, for up to an aggregate of $450,000. On January 20, 2023, the first installment
of the Extension Funds was deposited into the Trust Account. The Extension Note bears no interest and is repayable in full upon the earlier
of (a) the date of the consummation of the initial Business Combination, and (b) the date of the liquidation of the Company.
As of June 30, 2023 and
December 31, 2022, there was $300,000 and $0 Related Party Extension Loans outstanding, respectively.
Advance from Related Party
As of June 30, 2023, the
Sponsor advanced $100,000, has paid for expenses totaling $144,597 on behalf of the Company of which $102,097 has been repaid and is
owed a total of $10,000 for administrative support services. As of December 31, 2022, the Sponsor has paid $67,910 on behalf of the Company.
$193,965 and $41,465 are included in advance from related party on the balance sheets as of June 30, 2023 and December 31, 2022, respectively.
Note 6 — Commitments and Contingencies
Registration Rights
The holders of the Founder
Shares, Private Placement Units and units that may be issued upon conversion of the Working Capital Loans (and all underlying securities)
will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of
the IPO. The holders of a majority of these securities will be entitled to make up to three demands that the Company register such securities.
In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415
under the Securities Act. However the registration rights provides that the Company will not permit any registration statement filed
under the Securities Act to become effective until termination of the applicable lock-up period. The registration rights agreement
does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities.
The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the
underwriters a 45-day option from the final prospectus relating to the IPO to purchase up to 1,125,000 additional Units to cover over-allotments,
if any, at the IPO price less the underwriting discounts and commissions. On January 21, 2022, the underwriters fully exercised their
over-allotment option and purchased 1,125,000 Units at $10.00 per Unit.
The underwriters were paid
an underwriting discount of $0.20 per unit, or $1,725,000 in the aggregate (including the Overallotment Units), upon the closing of the
IPO. An additional $0.35 per unit, or $3,018,750 in the aggregate, is payable to the underwriters for deferred underwriting commissions.
The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company
completes a Business Combination, subject to the terms of the underwriting agreement.
Right of First Refusal
Subject to certain conditions,
the Company granted Maxim, for a period beginning on the closing of the IPO and ending 18 months after the date of the consummation
of a Business Combination, a right of first refusal to act as lead left book-running managing underwriter with at least 75% of the
economics; or, in the case of a three-handed deal 50% of the economics, for any and all future public and private equity, convertible
and debt offerings for the Company or any of the Company’s successors or subsidiaries. In accordance with FINRA Rule 5110(f)(2)(E)(i),
such right of first refusal shall not have a duration of more than three years from the effective date of the IPO.
Unit Purchase Option
The Company sold to the
underwriters, for $100, an option to purchase up to a total of 431,250 Units exercisable, in whole or in part, at $11.00 per Unit, commencing
on the consummation of our initial Business Combination (the “Unit Purchase Option”). The purchase option may be exercised
for cash or on a cashless basis, at the holder’s option, and expires five years from January 18, 2022. The option and the 431,250
Units, as well as the 431,250 shares of Class A ordinary shares, and the rights to receive 43,125 shares of Class A ordinary shares
upon a Business Combination that may be issued upon exercise of the option, have been deemed compensation by FINRA and are therefore
subject to a lock-up for a period of 180 days immediately following January 18, 2022 pursuant to Rule 5110(e)(1) of FINRA’s Rules,
during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale,
derivative or put or call transaction that would result in the economic disposition of the securities. Additionally, the option may not
be sold, transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180-day period) following January
18, 2022 except to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The option
grants to holders demand and “piggy-back” rights of the securities directly and indirectly issuable upon exercise of the
option. Notwithstanding the foregoing, the underwriters and their related persons may not (i) have more than one demand registration
right at our expense, (ii) exercise their demand registration rights more than five (5) years from January 18, 2022, and (iii) exercise
their “piggy-back” registration rights more than seven (7) years from January 18, 2022. The Company will bear all fees and
expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves.
The exercise price and number of units issuable upon exercise of the option may be adjusted in certain circumstances including in the
event of a stock dividend, or our recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted
for issuances of shares of ordinary shares at a price below its exercise price. The Company has no obligation to net cash settle the
exercise of the purchase option or the rights underlying the purchase option. The holder of the purchase option will not be entitled
to exercise the purchase option unless a registration statement covering the securities underlying the purchase option is effective or
an exemption from registration is available. If the holder is unable to exercise the purchase option or underlying rights, the purchase
option or rights, as applicable, will expire worthless.
The Company accounted for the
Unit Purchase Option, inclusive of the receipt of $100 cash payment, as an expense of the IPO resulting in a charge directly to shareholders’
deficit. The Company estimated the fair value of Unit Purchase Option to be $56,000 based a binomial model.
Note 7 — Shareholders’ Deficit
Preference Shares —The
Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other
rights and preferences as may be determined from time to time by the Company’s Board. As of June 30, 2023 and December 31, 2022,
there were no preference shares issued or outstanding.
Class A Ordinary
shares —The Company is authorized to issue 50,000,000 shares of Class A ordinary shares with a par value of $0.0001
per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there
were 470,975 shares of Class A ordinary shares outstanding (excluding 1,001,302 and 8,625,000 shares of Class A ordinary shares subject
to possible redemption, respectively).
Class B Ordinary
shares — The Company is authorized to issue 3,000,000 shares of Class B ordinary shares with a par value of $0.0001
per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022,
there were 2,156,250 shares of Class B ordinary shares outstanding.
Holders of shares of Class
A ordinary shares and shares of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote
of shareholders.
The shares of Class B ordinary
shares will automatically convert into shares of Class A ordinary shares at the time of the initial Business Combination on a one-for-one
basis, subject to adjustment. In the case that additional shares of Class A ordinary shares, or equity-linked securities, are issued
or deemed issued in excess of the amounts offered in the IPO and related to the closing of the initial Business Combination, the ratio
at which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders
of a majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or
deemed issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares
will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of ordinary shares outstanding
upon the completion of the IPO plus all shares of Class A ordinary shares and equity-linked securities issued or deemed issued in connection
with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the
initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of
loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal
number of shares of Class A ordinary shares, subject to adjustment as provided above, at any time.
Rights —
Except in cases where the Company is not the surviving company in a Business Combination, each holder of a Public Right will automatically
receive one-tenth (1/10) of one share of Class A ordinary share upon consummation of a Business Combination, even if the holder of a
Public Right converted all shares held by him, her or it in connection with a Business Combination or an amendment to the Company’s
Amended and Restated Certificate of Incorporation with respect to its pre-Business Combination activities. In the event that the Company
will not be the surviving company upon completion of a Business Combination, each holder of a Public Right will be required to affirmatively
convert his, her or its rights in order to receive the one-tenth (1/10) of a share underlying each Public Right upon consummation of
the Business Combination. No additional consideration will be required to be paid by a holder of Public Rights in order to receive his,
her or its additional shares of Class A ordinary share upon consummation of a Business Combination. The shares issuable upon exchange
of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive
agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for
the holders of rights to receive the same per share consideration the holders of the ordinary shares will receive in the transaction
on an as-converted into ordinary share basis.
The Company will not issue
fractional shares in connection with an exchange of Public Rights. Fractional shares will either be rounded down to the nearest whole
share or otherwise addressed in accordance with the applicable provisions of local law. As a result, the holders of the Public Rights
must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a Business Combination.
If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in
the Trust Account, holders of Public Rights will not receive any of such funds with respect to their Public Rights, nor will they receive
any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Rights, and the Public
Rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the Public
Rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights.
Accordingly, the rights may expire worthless.
Note 8 — Fair Value Measurements
The fair value of the Company’s
financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with
the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants
at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the
use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal
assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify
assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1: Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.
Level 3: Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
At June 30, 2023 and December
31, 2022, the assets held in the Trust Account were held in treasury funds. All of the Company’s investments held in the Trust
Account are classified as trading securities.
The following table presents
information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2023 and
December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
| |
| | |
Quoted Prices in Active Markets | | |
Significant Other Observable Inputs | | |
Significant Other Unobservable Inputs | |
June 30, 2023 | |
Level | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Investment held in Trust Account | |
| 1 | | |
$ | 10,911,923 | | |
| — | | |
| — | |
| |
| | |
Quoted Prices in Active Markets | | |
Significant Other Observable Inputs | | |
Significant Other Unobservable Inputs | |
December 31, 2022 | |
Level | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Investment held in Trust Account | |
| 1 | | |
$ | 88,525,575 | | |
| — | | |
| — | |
Note 9 — Subsequent Events
The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the financial statement was issued and determined
that there have been no events that have occurred that would require adjustments to or disclosures in the financial statement.
Item 2. Management’s Discussion and
Analysis of Financial Condition and Results of Operations.
References to the “Company,”
“us,” “our” or “we” refer to AIB Acquisition Corporation. The following discussion and analysis of
our financial condition and results of operations should be read in conjunction with our audited financial statements and related notes
included herein.
Cautionary Note Regarding
Forward-Looking Statements
All statements other than
statements of historical fact included in this Quarterly Report on Form 10-Q (this “Report”) including, without limitation,
statements under this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations”
regarding our financial position, business strategy and the plans and objectives of management for future operations, are forward- looking
statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,”
“intend” and similar expressions, as they relate to us or our management, identify forward-looking statements. Such forward-looking
statements are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management.
Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed
in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf
are qualified in their entirety by this paragraph.
The following discussion
and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial
statements and the notes thereto included in this Report under “Item 1 Financial Statements”. Certain information contained
in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Overview
We are a blank check company
formed for the purpose of effecting a Business Combination. We intend to effectuate our Business Combination using cash from the proceeds
of our IPO and the sale of the placement units that occurred simultaneously with the completion of our IPO, our capital stock, debt or
a combination of cash, stock and debt.
We expect to continue to incur
significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will
be successful.
Results of Operations
We have neither engaged
in any operations nor generated any operating revenues to date. Our only activities from inception through June 30, 2023 were organizational
activities and those necessary to prepare for the IPO, described below, and since the IPO, the search for a prospective initial Business
Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination, at the
earliest. We expect to generate non-operating income in the form of interest income from the proceeds of the IPO placed in the Trust
Account. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting
and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.
For the three months ended
June 30, 2023, we had a net loss of $330,507, which primarily consists of general and administrative expenses of $461,528, offset by interest
earned on investments held in the Trust Account of $130,370 and unrealized gain on investments held in the Trust Account of $651.
For the three months ended
June 30, 2022, we had a net loss of $71,467, which primarily consists of general and administrative expenses of $193,269 and unrealized
loss on investments held in the Trust Account of $7,526, offset by interest earned on investments held in the Trust Account of $129,328.
For the six months ended June
30, 2023, we had a net loss of $339,380, which primarily consists of general and administrative expenses of $750,204, offset by interest
earned on investments held in the Trust Account of $407,099 and unrealized gain on investments held in the Trust Account of $3,725.
For the six months ended June
30, 2022, we had a net loss of $273,500, which primarily consists of general and administrative expenses of $421,399 and unrealized loss
on investments held in the Trust Account of $13,518, offset by interest earned on investments held in the Trust Account of $161,417.
Liquidity and Going Concern
As of June 30, 2023, the Company
had $131,567 in its operating bank account, and working capital of $609,980, which excludes investments held in the Trust Account, the
liability for convertible note and deferred underwriting fee.
Our liquidity needs up to the
closing of the IPO on January 21, 2022 were satisfied through proceeds from notes payable and advances from related party and from the
issuance of common stock.
In order to finance transaction
costs in connection with an initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors
may, but are not obligated to, provide us with Working Capital Loans. The management plans to continue its efforts to complete an initial
Business Combination within the Combination Period.
On January 20, 2023, we issued
the Extension Note, a promissory note in the aggregate principal amount of up to $450,000 to the Sponsor, pursuant to which the Extension
Funds will be deposited into the Trust Account in monthly installments for the benefit of each outstanding Public Share that was not redeemed
in connection with the extension of the end of the Combination Period from January 21, 2023 to October 21, 2023. The Sponsor has agreed
to pay $50,000 per month that the Board decides to take to complete an initial Business Combination into the Trust Account, which equates
to approximately $0.05 per remaining Public Share, for each calendar month (commencing on January 21, 2023 and continuing through October
21, 2023, or portion thereof), for up to an aggregate of $450,000. On January 20, 2023, the first installment of the Extension Funds was
deposited into the Trust Account. As of June 30, 2023, $300,000 had been deposited into the Trust Account.
On January 23, 2023, we issued
the Working Capital Note, a promissory note in the principal amount of up to $500,000 to the Sponsor. The Working Capital Note was issued
in connection with advances the Sponsor has made, and may make in the future, to us for working capital expenses. The Working Capital
Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which we consummate our initial Business Combination
and (ii) the date that our winding up is effective. At the election of the Sponsor, up to $500,000 of the unpaid principal amount of the
Working Capital Note may be converted into Conversion Units, each Conversion Unit consisting of one Class A ordinary share and one right
exchangeable into one-tenth of one Class A ordinary share, equal to: (x) the portion of the principal amount of this Working Capital Note
being converted, divided by (y) $10.00, rounded up to the nearest whole number of units. The Conversion Units are identical to the units
issued by us to the Sponsor in the private placement. The Conversion Units and their underlying securities are entitled to the registration
rights set forth in the Working Capital Note. As of June 30, 2023, there was an outstanding balance of $500,000 on the Working Capital
Note.
If our estimate of the costs
of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount
necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may
need to obtain other financing either to complete our Business Combination or because we become obligated to redeem a significant number
of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in
connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing
simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not
have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our
Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
On January 19, 2023, upon the
shareholders’ approval, we entered into an amendment to the Trust Agreement to extend the date by which we are required to consummate
a Business Combination from January 21, 2023 to October 21, 2023, or such earlier date as determined by the Board, in its sole discretion.
As a result, we have up to 21 months from the closing of the IPO on January 21, 2022 to consummate an initial Business Combination, unless
further extended as permitted by our second amended and restated memorandum and articles of association. It is uncertain that we will
be able to consummate an initial Business Combination by this time. If an initial Business Combination is not consummated by this date,
there will be a mandatory liquidation and subsequent dissolution.
In connection with the our
assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements —
Going Concern,” management has determined that mandatory liquidation, should an initial Business Combination not occur, and potential
subsequent dissolution raises substantial doubt about the our ability to continue as a going concern for a reasonable period of time,
which is considered to be one year from the issuance of the financial statements.
JOBS Act
On April 5, 2012, the JOBS
Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying
public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new
or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay
the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the
relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our financial statements may
not be comparable to companies that comply with public company effective dates.
Additionally, we are in
the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain
conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not
be required to, among other things, (i) provide an auditor’s attestation report on our system of internal control over financial
reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of
non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement
that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional
information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation
related items such as the correlation between executive compensation and performance and comparisons of executive compensation to median
employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no
longer an “emerging growth company,” whichever is earlier.
Critical Accounting Policies
The preparation of condensed
financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent
assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual
results could materially differ from those estimates.
Net Loss per Ordinary Share
The Company has two outstanding
classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares (the “Founder Shares”). Class
A shares include redeemable and non-redeemable shares. Earnings and losses are shared pro rata between the two classes of shares which
includes Class A ordinary shares and Class B ordinary shares and between the redeemable and the non-redeemable shares. The 1,472,277
Class A ordinary shares for which the outstanding Public Rights and Private Placement Rights are exercisable were excluded from diluted
earnings per share for the period ended June 30, 2023 because they are contingently exercisable, and the contingencies have not yet been
met. As a result, diluted net loss per ordinary shares is the same as basic net loss per ordinary share for the period.
Recent Accounting Standards
In August 2020, the FASB
issued Accounting Standards Update (“ASU”) No. 2020-06, Debt — debt with Conversion and Other Options (Subtopic 470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments
and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by
removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required
for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation
in certain areas. The Company adopted ASU 2020-06 on June 18, 2021 (inception). Adoption of the ASU did not impact the Company’s
financial position, results of operations or cash flows.
Management does not believe
that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our
financial statements.
Factors That May Adversely Affect Our Results of Operations
Our results of operations and our ability to complete an initial Business
Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets,
many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in
economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence
and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical
instability, such as the military conflict in Ukraine. We cannot at this time fully predict the likelihood of one or more of the above
events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial
Business Combination.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting
company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Under the supervision and
with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer (together, the “Certifying
Officers”), we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures
as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our
disclosure controls and procedures were effective as of the end of the period covered by this Report.
Disclosure controls and
procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted
under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and
forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required
to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our
Certifying Officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial
Reporting
Not applicable.
PART II: Other Information
Item 1. Legal Proceedings.
To the knowledge of our
management team, there is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity
as such or against any of our property.
Item 1A. Risk Factors.
As a smaller reporting company under Rule 12b-2 of the Exchange Act,
we are not required to include risk factors in this Report. As of the date of this Report, other than as set forth below, there have been
no material changes to the risk factors previously disclosed in our (i) our final prospectus filed with the SEC for our IPO; (ii) Annual
Report on Form 10-K for the fiscal years ended December 31, 2022 and 2021, as filed with the SEC on March 29, 2023 and on March 29, 2022,
respectively; and (iii) Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2023, September 30, 2022, June 30, 2022,
March 31, 2022, as filed with the SEC on May 15, 2023, November 14, 2022, August 10, 2022 and May 13, 2022, respectively. Any of these
factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks
could arise that may also affect our business or ability to consummate an initial Business Combination. We may disclose changes to such
risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
Market conditions, economic uncertainty
or downturns could adversely affect our business, financial condition, operating results and our ability to consummate a Business Combination.
In recent years, the United
States and other markets have experienced cyclical or episodic downturns, and worldwide economic conditions remain uncertain, including
as a result of the COVID-19 pandemic, supply chain disruptions, the Ukraine-Russia conflict, instability in the U.S. and global banking
systems, rising fuel prices, increasing interest rates or foreign exchange rates and high inflation and the possibility of a recession.
A significant downturn in economic conditions may make it more difficult for us to consummate a Business Combination.
We cannot predict the timing,
strength, or duration of any future economic slowdown or any subsequent recovery generally, or in any industry. If the conditions in the
general economy and the markets in which we operate worsen from present levels, our business, financial condition, operating results and
our ability to consummate a Business Combination could be adversely affected.
If our initial Business Combination involves
a company organized under the laws of a state of the United States, it is possible a 1% U.S. federal excise tax will be imposed on us
in connection with redemptions of our common stock after or in connection with such initial Business Combination.
On August 16, 2022, the IR
Act became law in the United States, which, among other things, imposes a 1% excise tax on the fair market value of certain repurchases
(including certain redemptions) of stock by publicly traded domestic (i.e., United States) corporations (and certain non-U.S. corporations
treated as “surrogate foreign corporations”). The excise tax will apply to stock repurchases occurring in 2023 and beyond.
The amount of the excise tax is generally 1% of the fair market value of the shares of stock repurchased at the time of the repurchase.
The Treasury has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the
excise tax; however, only limited guidance has been issued to date.
As an entity incorporated
as a Cayman Islands exempted company, the 1% excise tax is not expected to apply to redemptions of our Class A ordinary shares (absent
any regulations and other additional guidance that may be issued in the future with retroactive effect).
However,
in connection with an initial Business Combination involving a company organized under the laws of the United States, it is possible that
we domesticate and continue as a Delaware corporation prior to certain redemptions and, because our securities are trading on The Nasdaq
Stock Market LLC, it is possible that we will be subject to the excise tax with respect to any subsequent redemptions, including redemptions
in connection with the initial Business Combination, that are treated as repurchases for this purpose (other than, pursuant to recently
issued guidance from the Treasury, redemptions in complete liquidation of the company). In all cases, the extent of the excise tax that
may be incurred will depend on a number of factors, including the fair market value of our stock redeemed, the extent such redemptions
could be treated as dividends and not repurchases, and the content of any regulations and other additional guidance from the Treasury
that may be issued and applicable to the redemptions. Issuances of stock by a repurchasing corporation in a year in which such corporation
repurchases stock may reduce the amount of excise tax imposed with respect to such repurchase. The excise tax is imposed on the repurchasing
corporation itself, not the shareholders from which stock is repurchased. The imposition of the excise tax as a result of redemptions
in connection with the initial Business Combination could, however, reduce the amount of cash available to pay redemptions or reduce the
cash contribution to the target business in connection with our initial Business Combination, which could cause the other shareholders
of the combined company to economically bear the impact of such excise tax.
There is substantial doubt about our ability
to continue as a “going concern.”
In connection with our assessment
of going concern considerations under applicable accounting standards, management has determined that our possible need for additional
financing to enable us negotiate and complete our initial Business Combination raise substantial doubt about our ability to continue as
a going concern through approximately one year from the date the unaudited condensed financial statements included in Item 1. “Financial
Statements” were issued.
Item 2. Unregistered Sales of
Equity Securities and Use of Proceeds
Unregistered Sales of
Equity Securities
None.
Use of Proceeds
For a description of the
use of proceeds generated in our IPO and private placement, see Part II, Item 5 of the Company’s Annual Report on Form 10-K for
the year ended December 31, 2021, as filed with the SEC on March 29, 2022. There has been no material change in the planned use of the
proceeds from our IPO and the private placement as is described in the Company’s final prospectus related to our IPO.
Purchases of Equity Securities
by the Issuer and Affiliated Purchasers
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information
None.
Item 6. Exhibits.
The following exhibits are
filed as part of, or incorporated by reference into, this Report.
* |
Filed
herewith. |
** |
Furnished
herewith |
SIGNATURES
Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Date:
August 11, 2023 |
AIB
ACQUISITION CORPORATION |
|
|
|
|
By: |
/s/
Eric Chen |
|
Name: |
Eric
Chen |
|
Title: |
Chief
Executive Officer |
|
|
(Principal
Executive Officer) |
|
|
|
|
By: |
/s/
Jie Gao |
|
Name: |
Jie
Gao |
|
Title: |
Chief
Financial Officer |
|
|
(Principal
Financial and Accounting Officer) |
25
00-0000000
1001302
1717340
7624309
8625000
0.00
0.11
0.17
0.40
416331
470975
470975
470975
0.02
0.17
0.24
1.28
2156250
2156250
2156250
2156250
0.02
0.17
0.24
1.28
0.11
0.17
0.17
0.17
0.24
0.24
false
--12-31
Q2
0001882963
0001882963
2023-01-01
2023-06-30
0001882963
aib:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneRightToReceiveOnetenth110OfOneClassAOrdinaryShareUponTheConsummationOfAnInitialBusinessCombinationMember
2023-01-01
2023-06-30
0001882963
aib:ClassAOrdinarySharesParValue00001PerShareMember
2023-01-01
2023-06-30
0001882963
aib:RightsEveryTen10RightsEntitlesTheHolderToReceiveOneClassAOrdinaryShareUponTheConsummationOfAnInitialCombinationMember
2023-01-01
2023-06-30
0001882963
us-gaap:CommonClassAMember
2023-08-11
0001882963
us-gaap:CommonClassBMember
2023-08-11
0001882963
2023-06-30
0001882963
2022-12-31
0001882963
us-gaap:CommonClassAMember
2023-06-30
0001882963
us-gaap:CommonClassAMember
2022-12-31
0001882963
us-gaap:CommonClassBMember
2023-06-30
0001882963
us-gaap:CommonClassBMember
2022-12-31
0001882963
2023-04-01
2023-06-30
0001882963
2022-04-01
2022-06-30
0001882963
2022-01-01
2022-06-30
0001882963
aib:RedeemableClassAOrdinarySharesMember
2023-04-01
2023-06-30
0001882963
aib:RedeemableClassAOrdinarySharesMember
2022-04-01
2022-06-30
0001882963
aib:RedeemableClassAOrdinarySharesMember
2023-01-01
2023-06-30
0001882963
aib:RedeemableClassAOrdinarySharesMember
2022-01-01
2022-06-30
0001882963
aib:NonRedeemableClassAOrdinarySharesMember
2023-04-01
2023-06-30
0001882963
aib:NonRedeemableClassAOrdinarySharesMember
2022-04-01
2022-06-30
0001882963
aib:NonRedeemableClassAOrdinarySharesMember
2023-01-01
2023-06-30
0001882963
aib:NonRedeemableClassAOrdinarySharesMember
2022-01-01
2022-06-30
0001882963
us-gaap:CommonClassBMember
2023-04-01
2023-06-30
0001882963
us-gaap:CommonClassBMember
2022-04-01
2022-06-30
0001882963
us-gaap:CommonClassBMember
2023-01-01
2023-06-30
0001882963
us-gaap:CommonClassBMember
2022-01-01
2022-06-30
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-12-31
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001882963
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001882963
us-gaap:RetainedEarningsMember
2022-12-31
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001882963
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001882963
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001882963
2023-01-01
2023-03-31
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-03-31
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001882963
us-gaap:RetainedEarningsMember
2023-03-31
0001882963
2023-03-31
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001882963
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001882963
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-06-30
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-06-30
0001882963
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001882963
us-gaap:RetainedEarningsMember
2023-06-30
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2021-12-31
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-12-31
0001882963
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001882963
us-gaap:RetainedEarningsMember
2021-12-31
0001882963
2021-12-31
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001882963
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0001882963
us-gaap:RetainedEarningsMember
2022-01-01
2022-03-31
0001882963
2022-01-01
2022-03-31
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-03-31
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-03-31
0001882963
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001882963
us-gaap:RetainedEarningsMember
2022-03-31
0001882963
2022-03-31
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001882963
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0001882963
us-gaap:RetainedEarningsMember
2022-04-01
2022-06-30
0001882963
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-06-30
0001882963
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-06-30
0001882963
us-gaap:RetainedEarningsMember
2022-06-30
0001882963
2022-06-30
0001882963
us-gaap:CommonClassAMember
us-gaap:IPOMember
2022-01-01
2022-01-21
0001882963
us-gaap:CommonClassAMember
2022-01-21
0001882963
us-gaap:PrivatePlacementMember
2023-01-01
2023-06-30
0001882963
us-gaap:PrivatePlacementMember
2023-06-30
0001882963
us-gaap:OverAllotmentOptionMember
2023-01-01
2023-06-30
0001882963
us-gaap:OverAllotmentOptionMember
2023-06-30
0001882963
aib:SponsorMember
us-gaap:PrivatePlacementMember
2023-06-30
0001882963
us-gaap:IPOMember
2023-06-30
0001882963
us-gaap:IPOMember
2023-01-01
2023-06-30
0001882963
aib:BusinessCombinationMember
2023-01-01
2023-06-30
0001882963
aib:BusinessCombinationMember
2023-06-30
0001882963
2023-01-01
2023-01-20
0001882963
2023-05-11
0001882963
2022-08-01
2022-08-16
0001882963
2023-04-01
2023-04-27
0001882963
2023-04-27
0001882963
us-gaap:CommonStockMember
2023-01-01
2023-01-18
0001882963
2023-01-01
2023-01-18
0001882963
2022-01-01
2022-12-31
0001882963
aib:RedeemableClassAMember
2023-04-01
2023-06-30
0001882963
aib:NonredeemableClassAMember
2023-04-01
2023-06-30
0001882963
aib:NonredeemableClassBMember
2023-04-01
2023-06-30
0001882963
aib:RedeemableClassAMember
2023-01-01
2023-06-30
0001882963
aib:NonredeemableClassAMember
2023-01-01
2023-06-30
0001882963
aib:NonredeemableClassBMember
2023-01-01
2023-06-30
0001882963
aib:RedeemableClassAMember
2022-04-01
2022-06-30
0001882963
aib:NonredeemableClassAMember
2022-04-01
2022-06-30
0001882963
aib:NonredeemableClassBMember
2022-04-01
2022-06-30
0001882963
aib:RedeemableClassAMember
2022-01-01
2022-06-30
0001882963
aib:NonredeemableClassAMember
2022-01-01
2022-06-30
0001882963
aib:NonredeemableClassBMember
2022-01-01
2022-06-30
0001882963
2023-01-18
0001882963
us-gaap:PrivatePlacementMember
2022-01-01
2022-01-21
0001882963
us-gaap:PrivatePlacementMember
2022-01-21
0001882963
aib:FounderSharesMember
2021-07-01
2021-07-30
0001882963
2021-07-01
2021-07-30
0001882963
aib:FounderSharesMember
us-gaap:CommonClassBMember
2021-09-01
2021-09-13
0001882963
aib:FounderSharesMember
2023-01-01
2023-06-30
0001882963
us-gaap:CommonClassAMember
2023-01-01
2023-06-30
0001882963
us-gaap:IPOMember
2021-07-30
0001882963
2023-01-01
2023-01-23
0001882963
2023-01-23
0001882963
2022-01-01
2022-01-21
0001882963
us-gaap:OverAllotmentOptionMember
2022-01-21
0001882963
2022-01-01
2022-01-18
0001882963
aib:UnitPurchaseOptionMember
2022-01-01
2022-01-18
0001882963
us-gaap:CommonClassAMember
2022-01-01
2022-01-18
0001882963
us-gaap:FairValueInputsLevel1Member
2023-06-30
0001882963
us-gaap:FairValueInputsLevel2Member
2023-06-30
0001882963
us-gaap:FairValueInputsLevel3Member
2023-06-30
0001882963
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001882963
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001882963
us-gaap:FairValueInputsLevel3Member
2022-12-31
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Quarterly Report of AIB
Acquisition Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities
and Exchange Commission (the “Report”), I, Eric Chen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
§1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
In connection with the Quarterly Report of AIB
Acquisition Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities
and Exchange Commission (the “Report”), I, Jie Gao, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
§1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: